title: Handling missing data in vaccine clinical trials for immunogenicity and safety evaluation.
abstract: In clinical trials, study subjects are usually followed for a period of time after treatment, and the missing data issue is almost inevitable due to various reasons, including early dropout or lost-to-follow-up. It is important to take the missing data into consideration at the study design stage to minimize its occurrence throughout the study and to prospectively account for it in the analyses. There are many methods available in the literature that are designed to handle the missing data issue under various settings. Vaccines are biological products that are primarily designed to prevent infectious diseases, and are different from pharmaceutical products, which traditionally have been chemical products designed to treat or cure diseases. While a lot of similarities exist between clinical trials for vaccines and those for pharmaceutical products, there are some unique issues in vaccine trials, including how to handle the missing data, which calls for special considerations. In this report we present a variety of statistical approaches for analyses of vaccine immunogenicity and safety trials in the presence of missing data. The methods are illustrated with numerical simulations and vaccine trial examples.
authors.affiliation: Merck Research Laboratories, North Wales, Pennsylvania, USA.
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Li
authors.forename: William W B
authors.initials: WW
authors.lastname: Wang
authors.forename: Guanghan F
authors.initials: GF
authors.lastname: Liu
authors.forename: Ivan S F
authors.initials: IS
authors.lastname: Chan
mesh_terms: D002986:Clinical Trials as Topic; D003198:Computer Simulation; D003627:Data Interpretation, Statistical; D023381:Endpoint Determination; D006801:Humans; D059012:Lost to Follow-Up; D015233:Models, Statistical; D010349:Patient Compliance; D010352:Patient Dropouts; D015203:Reproducibility of Results; D012107:Research Design; D014612:Vaccines / Q000009:adverse effects* / Q000276:immunology*
chemical_list: D014612:Vaccines